IMPEDIMED LIMITED — Board/Management Information 2009

Aug 17, 2009

18[th] August 2009

==> picture [110 x 104] intentionally omitted <==

----- Start of picture text ----- ASX : IPD----- End of picture text -----

ASX RELEASE – CFO ROLE RELOCATION TO US

ImpediMed CEO Greg Brown today announced the decision to relocate the role of Chief Financial Officer to the Group’s San Diego facility in the United States. In 2008 the Company made a strategic choice to establish the San Diego facility as the global operations hub, to support a focus on the Group’s key growth market in the US. In driving this transition, the board recently took the decision that it made strategic sense to relocate the CFO’s role to the US.

CEO Greg Brown today announced that as a result of this strategic direction, the current CFO and Company Secretary, Phil Auckland has sought and secured a new Australian based executive role, and has tendered his resignation to be effective on 25[th] September 2009.

The process to select a US based CFO has commenced with first round interviews.

Following Mr Auckland’s departure in September, the Australian based Group Finance Manager, Kym Fletcher, a Chartered Accountant with solid experience in audit with Deloitte and in senior commercial roles, will fulfil the financial leadership responsibilities on an interim basis until a new CFO is appointed. The Company Secretarial responsibilities will be fulfilled by an independent party.

Mr Auckland has agreed to support the transition to a new US based CFO by making available a limited amount of his personal time until an appointment has been made, and through the appointee’s induction.

Mr Brown said “I would like to take the opportunity to thank Phil for five years of dedication and achievement managing organisational growth, the intellectual property portfolio, numerous capital raisings and an extensive change program.”

Mr Auckland said “It has been a wonderful and rewarding challenge to have been a part of taking ImpediMed’s commercialisation strategy to this point. The board is making exactly the right decision to structure the senior team with the CFO now on the ground in the US, and I look forward to seeing ImpediMed complete its value creation journey for shareholders.”

Greg Brown Chief Executive Officer